The Infection of aortic valve graft conduit is a relatively rare complication still burdened by notable morbidity and mortality. Medical and surgical strategies play a crucial role in patient outcome and vary depending on infection extends into adjacent cardiac structures, systemic spread and identify microbes.
In this retrospective and observational study, we report two centre experience in the management of thirty patients consecutively admitted to our centre with composite aortic valve graft infection during the period 2008-2020. Our end-points were: infection control, early mortality and long-term survivor.
Twenty patients underwent redo surgery with an early mortality of 10% and a survival of 83% at 7-year follow-up. Ten patients were treated medically and experienced an early mortality of 30% and a mid-term survival of 33%. Patients with stable haemodynamic in the absence of local and systemic complications had an acceptable survival after lone antibiotic therapy.